USPTO serial 79445800
TRIMTAC
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- OSGOOD, KRYSTINA E
- Law office
- TMO LAW OFFICE 121
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with TRIMTAC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and medical preparations and substances; preparations for use in targeted and personalized pharmaceutical therapies; pharmaceutical preparations and substances for the treatment of diseases, including neurological, neurodegenerative, inflammatory and oncological diseases; biopharmaceuticals for the treatment of diseases, including neurological, neurodegenerative, inflammatory and oncological diseases; drugs for medical purposes; oral drugs for medical purposes; drugs for medical use for the degradation of toxins; pharmaceutical preparations in the fields of medicine, health, neurology, neurodegenerative diseases, inflammatory diseases, oncology, microorganisms and cells; biological preparations for medical purposes; biological compounds for use in targeted and personalized pharmaceutical therapies; proteins, reagents and cultures, all for medical purposes; proteins with diagnostic and therapeutic uses; drug delivery agents that facilitate the delivery of pharmaceutical preparations; diagnostic test kits for medical purposes. | ACTIVE | — |
| 042 | Drug development services; scientific consultancy; laboratory services; provision of information and data relating to medical research and development; medical and pharmacological research and development services; scientific research; biochemical and biological research; clinical research; laboratory research; research and development services in the field of medical therapeutics, including in the fields of neurology, neurodegenerative diseases, inflammatory diseases, oncology, microorganisms and cells; research and development services in the field of drug development, protein testing, and degradation of aggregated proteins; research, development and design of scientific and medical testing and screening products; scientific testing services; biological testing; information, consultancy and advisory services relating to the aforesaid. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 6, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 18, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 18, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 30, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 29, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 28, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| May 14, 2026 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Mar 16, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 16, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 12, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |